IPG
43
4
SLB
60
12
VLO
46
7
KMI
44
-2
NEM
49
-8
KHC
36
2
CA
40
8
SE
27
-14
LH
50
10
THC
73
3
XOM
62
3
AMP
70
12
WY
47
5
WM
65
-12
VNO
50
3
TXN
40
-2
BLK
55
-9
CSX
48
2
SO
59
-3
STI
24
-2
IPG
43
4
SLB
60
12
VLO
46
7
KMI
44
-2
NEM
49
-8
KHC
36
2
CA
40
8
SE
27
-14
LH
50
10
THC
73
3
XOM
62
3
AMP
70
12
WY
47
5
WM
65
-12
VNO
50
3
TXN
40
-2
BLK
55
-9
CSX
48
2
SO
59
-3
STI
24
-2
Financhill
Back

Altimmune Stock Predictions

$1,300 into $45,000 in just 4 MONTHS?!

See here to see the full details.
Sell
44

ALT
Altimmune

Last Price:
6.75
Seasonality Move:
1.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street

See the remarkable discovery.

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 50.9% based on the past 18 years of stock performance.
  • Altimmune has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $6.68. The Score for ALT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 50.9% based on the past 18 years of stock performance.

Altimmune Stock Rating

Sell
44
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
2.09

Prediction Charts

Market Cap:
473.27M
Price in USD:
6.68
Volume:
3.11M
Beta:
1.16

Technical Analysis

SMA50:
7.03
SMA100:
7.78
SMA200:
7.31
52-Wk Change:
122.5%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 6.68 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 6.74 6.89 7.14 6.72
Jul-9 6.83 6.90 7.00 6.56
Jul-10 6.96 7.48 7.53 6.77
Jul-11 7.68 7.68 8.03 7.41
Jul-12 7.79 7.90 8.00 7.61
Jul-15 8.01 7.90 8.15 7.73
Jul-16 7.92 8.10 8.26 7.75
Jul-17 7.75 7.47 8.05 7.27
Jul-18 7.55 6.55 7.56 6.48
Jul-19 6.58 6.28 6.63 6.26
Jul-22 6.43 6.37 6.48 6.09
Jul-23 6.30 6.43 6.52 6.16
Jul-24 6.30 6.27 6.59 6.24
Jul-25 6.37 6.68 6.84 6.35

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.54 per share, an increase this year of $0.64 per share, and a decrease next year of $0.73 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.